218 related articles for article (PubMed ID: 19668298)
1. [The clinical impact of the physiological effects of erythropoietin and erythropoietin-stimulating agents on the incidence of malignancy, and hypertension: beyond anaemia].
Ortega LM; Contreras G
Nefrologia; 2009; 29(4):288-94. PubMed ID: 19668298
[TBL] [Abstract][Full Text] [Related]
2. Beyond anemia: the clinical impact of the physiologic effects of erythropoietin.
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Semin Dial; 2008; 21(5):447-54. PubMed ID: 18573136
[TBL] [Abstract][Full Text] [Related]
3. [Erythropoietin--physiology and therapeutic potentialities].
Möllmann M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Dec; 27(8):461-8. PubMed ID: 1489869
[TBL] [Abstract][Full Text] [Related]
4. Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA).
Krapf R; Hulter HN
Clin J Am Soc Nephrol; 2009 Feb; 4(2):470-80. PubMed ID: 19218474
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin in cancer patients: pros and cons.
Dicato M; Plawny L
Curr Opin Oncol; 2010 Jul; 22(4):307-11. PubMed ID: 20498598
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin: mechanisms of action and indications for treatment.
Vreugdenhil G; Frenken LA; Koene RA
Neth J Med; 1993 Jun; 42(5-6):187-202. PubMed ID: 8377877
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of erythropoietin.
Jelkmann W
Intern Med; 2004 Aug; 43(8):649-59. PubMed ID: 15468961
[TBL] [Abstract][Full Text] [Related]
8. The erythropoietin receptor in normal and cancer tissues.
Jelkmann W; Bohlius J; Hallek M; Sytkowski AJ
Crit Rev Oncol Hematol; 2008 Jul; 67(1):39-61. PubMed ID: 18434185
[TBL] [Abstract][Full Text] [Related]
9. [Erythropoietin: indications and measurement].
Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
[TBL] [Abstract][Full Text] [Related]
10. The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression.
Hedley BD; Allan AL; Xenocostas A
Clin Cancer Res; 2011 Oct; 17(20):6373-80. PubMed ID: 21750199
[TBL] [Abstract][Full Text] [Related]
11. A truncated erythropoietin receptor EPOR-T is associated with hypertension susceptibility.
Carruthers SG
Clin Pharmacol Ther; 2009 Aug; 86(2):134-6. PubMed ID: 19621008
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic complications of erythropoiesis-stimulating agents.
Lippi G; Franchini M; Favaloro EJ
Semin Thromb Hemost; 2010 Jul; 36(5):537-49. PubMed ID: 20632251
[TBL] [Abstract][Full Text] [Related]
13. Use of recombinant human erythropoietin as an antianemic and performance enhancing drug.
Jelkmann W
Curr Pharm Biotechnol; 2000 Jul; 1(1):11-31. PubMed ID: 11467358
[TBL] [Abstract][Full Text] [Related]
14. [Physiology of eryhtropoietin and its therapeutic use].
Casadevall N
Ann Pharm Fr; 1996; 54(4):151-6. PubMed ID: 8881101
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin-- measurement and clinical applications.
Marsden JT
Ann Clin Biochem; 2006 Mar; 43(Pt 2):97-104. PubMed ID: 16536911
[TBL] [Abstract][Full Text] [Related]
16. Anemia management in oncology and hematology.
Spivak JL; Gascón P; Ludwig H
Oncologist; 2009; 14 Suppl 1():43-56. PubMed ID: 19762516
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin: physiology and clinical experience.
Varet B; Casadevall N; Lacombe C; Nayeaux P
Semin Hematol; 1990 Jul; 27(3 Suppl 3):25-31. PubMed ID: 2198661
[TBL] [Abstract][Full Text] [Related]
18. Stimulating erythropoiesis: future perspectives.
Mikhail A; Covic A; Goldsmith D
Kidney Blood Press Res; 2008; 31(4):234-46. PubMed ID: 18587242
[TBL] [Abstract][Full Text] [Related]
19. Biology of erythropoietin.
Jelkmann W
Clin Investig; 1994; 72(6 Suppl):S3-10. PubMed ID: 7950169
[TBL] [Abstract][Full Text] [Related]
20. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E
Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
